<SEC-DOCUMENT>0002095702-25-000002-index.html : 20251110
<SEC-HEADER>0002095702-25-000002.hdr.sgml : 20251110
<ACCEPTANCE-DATETIME>20251110210759
ACCESSION NUMBER:		0002095702-25-000002
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20251031
FILED AS OF DATE:		20251110
DATE AS OF CHANGE:		20251110

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Bulis Veronica Sanchez
		CENTRAL INDEX KEY:			0002095702
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40502
		FILM NUMBER:		251468035

	MAIL ADDRESS:	
		STREET 1:		C/O LYELL IMMUNOPHARMA, INC.
		STREET 2:		201 HASKINS WAY, SUITE 101
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lyell Immunopharma, Inc.
		CENTRAL INDEX KEY:			0001806952
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				833006753
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		201 HASKINS WAY
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		650 695-0677

	MAIL ADDRESS:	
		STREET 1:		201 HASKINS WAY
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>form3-11112025_021155.xml
<TEXT>
Document 1 - file: form3-11112025_021155.html

Document 1 - RAW XML: form3-11112025_021155.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>ex24-11112025_021157.htm
<TEXT>
Document 2 - file: ex24-11112025_021157.htm

</DOCUMENT>
</SEC-DOCUMENT>